首页> 外文期刊>Biomaterials >Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering.
【24h】

Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering.

机译:嵌入PLGA微粒的微孔丝素蛋白支架可用于组织工程中的受控生长因子递送。

获取原文
获取原文并翻译 | 示例
           

摘要

The development of prototype scaffolds for either direct implantation or tissue engineering purposes and featuring spatiotemporal control of growth factor release is highly desirable. Silk fibroin (SF) scaffolds with interconnective pores, carrying embedded microparticles that were loaded with insulin-like growth factor I (IGF-I), were prepared by a porogen leaching protocol. Treatments with methanol or water vapor induced water insolubility of SF based on an increase in beta-sheet content as analyzed by FTIR. Pore interconnectivity was demonstrated by SEM. Porosities were in the range of 70-90%, depending on the treatment applied, and were better preserved when methanol or water vapor treatments were prior to porogen leaching. IGF-I was encapsulated into two different types of poly(lactide-co-glycolide) microparticles (PLGA MP) using uncapped PLGA (50:50) with molecular weights of either 14 or 35 kDa to control IGF-I release kinetics from the SF scaffold. Embedded PLGA MP were located in the walls or intersections of the SF scaffold. Embedment of the PLGA MP into the scaffolds led to more sustained release rates as compared to the free PLGA MP, whereas the hydrolytic degradation of the two PLGA MP types was not affected. The PLGA types used had distinct effects on IGF-I release kinetics. Particularly the supernatants of the lower molecular weight PLGA formulations turned out to release bioactive IGF-I. Our studies justify future investigations of the developed constructs for tissue engineering applications.
机译:非常需要开发用于直接植入或组织工程目的且具有时空控制生长因子释放的原型支架。通过成孔剂浸取方案制备了带有连通孔的丝素蛋白(SF)支架,该支架带有嵌入的微粒,该微粒装载有胰岛素样生长因子I(IGF-1)。 FTIR分析表明,基于β片层含量的增加,用甲醇或水蒸气进行处理会导致SF的水不溶性。 SEM证明了孔的互连性。孔隙率在70-90%的范围内,具体取决于所应用的处理,并且在进行致孔剂浸出之前进行甲醇或水蒸气处理时,孔隙率可得到更好的保存。使用分子量为14或35 kDa的未封端PLGA(50:50)将IGF-I封装到两种不同类型的聚(丙交酯-共-乙交酯)微粒(PLGA MP)中,以控制IGF-I从SF释放的动力学脚手架。嵌入式PLGA MP位于SF支架的墙壁或交叉点中。与游离PLGA MP相比,将PLGA MP嵌入支架中可导致更高的持续释放速率,而两种PLGA MP类型的水解降解均不受影响。使用的PLGA类型对IGF-1释放动力学具有明显的影响。特别地,较低分子量PLGA制剂的上清液被证明释放生物活性IGF-1。我们的研究证明了对用于组织工程应用的已开发构建体进行进一步研究的合理性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号